63 related articles for article (PubMed ID: 33613568)
1. Association of Anti-CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti-Transcriptional Intermediary Factor 1γ-Positive Dermatomyositis.
Fiorentino D; Mecoli CA; Igusa T; Albayda J; Paik JJ; Tiniakou E; Adler B; Mammen AL; Shah AA; Rosen A; Christopher-Stine L; Casciola-Rosen L
Arthritis Rheumatol; 2023 Jul; 75(7):1238-1245. PubMed ID: 36762496
[TBL] [Abstract][Full Text] [Related]
2. Remarkable remission of symptomatic dermatomyositis after curative breast cancer surgery.
Fujino M; Kawashima M; Yoshifuji H; Nakashima R; Yamada Y; Matsumoto Y; Kawaguchi-Sakita N; Mori Y; Pu F; Yamaguchi A; Kawaguchi K; Takada M; Toi M
Int Cancer Conf J; 2024 Apr; 13(2):111-118. PubMed ID: 38524641
[TBL] [Abstract][Full Text] [Related]
3. Rapidly progressive erosions and ulcerations in a patient with cancer-associated anti-TIF-1γ/α and anti-U1 RNP-positive dermatomyositis: A case report.
Rosseels W; Vulsteke JB; Bosisio F; Satoh M; De Langhe E; De Haes P
J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):e1403-e1404. PubMed ID: 37458524
[No Abstract] [Full Text] [Related]
4. Research progress on the dermatomyositis specific autoantibodies and malignancy associated dermatomyositis.
Xu Y; Yang Y; Fan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1890-1898. PubMed ID: 38448383
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of commercial panels to evaluate myositis autoantibodies: A single-institution perspective.
Ravishankar A; Concha JS; Yan D; Bax CE; Yeguez AC; Casciola-Rosen L; Werth VP
J Am Acad Dermatol; 2021 Feb; 84(2):572-574. PubMed ID: 32896596
[No Abstract] [Full Text] [Related]
6. Hallux patch during anti-TIF-1γ dermatomyositis.
Kluger N
Clin Exp Dermatol; 2024 Apr; ():. PubMed ID: 38641559
[No Abstract] [Full Text] [Related]
7. Deep RNA sequencing of muscle tissue reveals absence of viral signatures in dermatomyositis.
Corman VM; Preusse C; Melchert J; Benveniste O; Koll R; Goebel HH; Jones TC; Drosten C; Schara-Schmidt U; Leonard-Louis S; Stenzel W; Radke J
Free Neuropathol; 2024 Jan; 5():. PubMed ID: 38205217
[No Abstract] [Full Text] [Related]
8. Dermatomyositis with positive anti-TIF1 gamma antibodies in an adult female: A case report.
Adhikari K; Pant P; Bhandari S; Paudel S; Poudyal B; Sharma L; Sigdel KR; Subedi R
Clin Case Rep; 2023 Nov; 11(11):e8215. PubMed ID: 38028105
[TBL] [Abstract][Full Text] [Related]
9. Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy.
Pachman LM; Nolan BE; DeRanieri D; Khojah AM
Curr Treatm Opt Rheumatol; 2021 Mar; 7(1):39-62. PubMed ID: 34354904
[TBL] [Abstract][Full Text] [Related]
10. A unique case of dermatomyositis associated with anti-TIF1γ antibody and chondrosarcoma.
Dziwis J; Agnihothri R; Lieberman A; Richardson CT
JAAD Case Rep; 2019 Sep; 5(9):828-830. PubMed ID: 31517008
[No Abstract] [Full Text] [Related]
11. Anti-transcriptional intermediary factor 1γ antibody-positive dermatomyositis with intravascular lymphoma.
Kokubu H; Takahashi T; Shiohara M; Matsubara A; Kato T; Nakanishi T; Fujimoto N
Eur J Dermatol; 2023 Jun; 33(3):314-316. PubMed ID: 37594349
[No Abstract] [Full Text] [Related]
12. Anti-TIF1-γ Antibody-Positive Dermatomyositis Leading to Identification of Diffuse Large B-Cell Lymphoma.
Otsuki T; Ishizuka K; Eto H; Nakano H; Kato Y; Sudo H; Motohashi I; Ie K; Ohira Y; Okuse C
J Gen Intern Med; 2024 May; ():. PubMed ID: 38710865
[No Abstract] [Full Text] [Related]
13. Clinical Images: Anti-transcriptional intermediary factor 1γ-positive dermatomyositis with trismus.
Owada Y; Fujikawa H; Suda M; Muranaka K; Minoda M
ACR Open Rheumatol; 2024 Apr; 6(4):203-204. PubMed ID: 38305073
[No Abstract] [Full Text] [Related]
14. Bullous dermatomyositis with anti-NPX2 antibodies, associated with breast cancer.
Reculé F; Benedetto J; Silva-Hirschberg C; Cabrera R; Castro A
An Bras Dermatol; 2024; 99(2):305-307. PubMed ID: 38135558
[No Abstract] [Full Text] [Related]
15. Reply.
Hou C; Authier FJ; Gitiaux C
Arthritis Rheumatol; 2021 Aug; 73(8):1566-1567. PubMed ID: 33645888
[No Abstract] [Full Text] [Related]
16. Autoantibody profiles delineate distinct subsets of scleromyositis.
Leclair V; D'Aoust J; Gyger G; Landon-Cardinal O; Meyer A; O'Ferrall E; Karamchandani J; Massie R; Ellezam B; Satoh M; Troyanov Y; Fritzler MJ; Hudson M;
Rheumatology (Oxford); 2022 Mar; 61(3):1148-1157. PubMed ID: 34146090
[TBL] [Abstract][Full Text] [Related]
17. ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis.
Selickaja S; Galindo-Feria AS; Dani L; Mimori T; Rönnelid J; Holmqvist M; Lundberg IE; Venalis P
Rheumatology (Oxford); 2022 Nov; 61(12):4991-4996. PubMed ID: 35579337
[TBL] [Abstract][Full Text] [Related]
18. Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies.
Mahler M; Malyavantham K; Seaman A; Bentow C; Anunciacion-Llunell A; Sanz-Martínez MT; Viñas-Gimenez L; Selva-O'Callaghan A
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943483
[TBL] [Abstract][Full Text] [Related]
19. Anti-TIF-1γ Antibody Detection Using a Commercial Kit vs In-House Immunoblot: Usefulness in Clinical Practice.
Mariscal A; Milán M; Baucells A; Martínez MA; Guillen AG; Trallero-Araguás E; Alvarado-Cardenas M; Martínez-Martínez L; Alserawan L; Franco-Leyva T; Sanz-Martínez MT; Viñas-Giménez L; Corominas H; Juárez C; Castellví I; Selva-O'Callaghan A
Front Immunol; 2020; 11():625896. PubMed ID: 33613568
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
